NASDAQ, ICCC - Immucell Corp
ImmuCell Corporation was founded in 1982 and completed an initial public
offering of common stock in 1987. We are an animal health biotechnology company
serving veterinarians and producers in the dairy and beef industries with
innovative and proprietary products that improve animal health and productivity.
After achieving approval from the U.S. Department of Agriculture (USDA) to sell
First Defense? in 1991, we spent most of our efforts during the 1990?s
developing human product applications of the underlying milk antibody
technology. Beginning in 1999, we re-focused our efforts on First Defense? and
other products for the dairy industry. With our shift in focus, we were able to
record net income for each of the past nine years. ...
Read SEC Filing on NASDAQ.com »